Stocksigma LogoStocksigma Logo

Aurobindo Pharma Step-Down Subsidiary Subscribes to 100% Capital in A1 Biochem USA

Aurobindo Pharma's step-down subsidiary, A1 Biochem Labs (India) Private Limited, subscribed to 10,000 equity shares of newly incorporated A1 Biochem USA

Aurobindo Pharma Step-Down Subsidiary Subscribes to 100% Capital in A1 Biochem USA

Aurobindo Pharma Ltd 路 Others (Uncategorized) 路 12 Sept 2026, 6:20 pm

Aurobindo Pharma Step-Down Subsidiary Subscribes to 100% Capital in A1 Biochem USA Aurobindo Pharma's step-down subsidiary, A1 Biochem Labs (India) Private Limited, subscribed to 10,000 equity shares of newly incorporated A1 Biochem USA Inc at USD 100 per share on 11th Sep'26, totaling a cash consideration of USD 1 mn. Following the subscription, A1 Biochem USA Inc is a 100% wholly owned subsidiary established to conduct Contract Research and Development (CRO/CDMO) services in the US. The transaction aligns with Aurobindo's earlier disclosed acquisition of the A1 Biochem Group on 23rd Jul'26.

Original exchange filing (PDF)

More announcements from Aurobindo Pharma Ltd

All Aurobindo Pharma Ltd announcements